MENU
FXH
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

FXH stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Health Care Index... Show more

Category: #Health
A.I.Advisor
published price charts
A.I.Advisor
a Summary for FXH with price predictions
Nov 10, 2026

FXH in upward trend: price rose above 50-day moving average on October 14, 2026

FXH moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend. In 33 of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on FXH as a result. In 79 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

The Moving Average Convergence Divergence (MACD) for FXH just turned positive on October 14, 2026. Looking at past instances where FXH's MACD turned positive, the stock continued to rise in 38 of 47 cases over the following month. The odds of a continued upward trend are 81%.

The 10-day moving average for FXH crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 81%.

Following a +4.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXH advanced for three days, in 239 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

The Aroon Indicator entered an Uptrend today. In 205 of 265 cases where FXH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Bearish Trend Analysis

The 10-day RSI Indicator for FXH moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 26 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 56 of 65 cases where FXH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

FXH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Bristol-Myers Squibb Co (NYSE:BMY).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Health Care Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.

Market Cap

The average market capitalization across the First Trust Health Care AlphaDEX Fund (FXH) ETF is 74.58B. The market cap for tickers in the group ranges from 4.04B to 1.21T. LLY holds the highest valuation in this group at 1.21T. The lowest valued company is NVST at 4.04B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Health Care AlphaDEX Fund (FXH) ETF was 1%. For the same ETF, the average monthly price growth was 7%, and the average quarterly price growth was 23%. MDLN experienced the highest price growth at 20%, while CAI experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the First Trust Health Care AlphaDEX Fund (FXH) ETF was -24%. For the same stocks of the ETF, the average monthly volume growth was -7% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 47
Price Growth Rating: 33
SMR Rating: 63
Profit Risk Rating: 68
Seasonality Score: 26 (-100 ... +100)